Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
<h4>Introduction</h4>Hepatic steatosis (HS) negatively impacts transplant outcomes in living liver donors. To date, liver biopsy is preferred for HS evaluation. This study aims to evaluate the measurement of controlled attenuation parameter (CAP) as a diagnostic tool of HS in living live...
Enregistré dans:
Auteurs principaux: | Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/562cc6dc058f45cbb183915d3b4a4d78 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
par: Bedriye Koyuncu Sokmen, et autres
Publié: (2021) -
Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
par: Khalid Bzeizi, et autres
Publié: (2021) -
Role of PAI-1 in hepatic steatosis and dyslipidemia
par: Joshua A. Levine, et autres
Publié: (2021) -
Cellular senescence drives age-dependent hepatic steatosis
par: Mikolaj Ogrodnik, et autres
Publié: (2017) -
Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
par: Tripolino C, et autres
Publié: (2019)